Coronary ectasia in familial hypercholesterolemia: Histopathologic study regarding matrix metalloproteinases

Modern Pathology

Volumn 12, Issue 12, 1999, Pages 1174-1180

  Kajinami, Kouji ^a,b   Kasashima, Satomi ^a   Oda, Yoshio ^a   Koizumi, Junji ^a   Katsuda, Shogo ^b   Mabuchi, Hiroshi ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Coronary ectasia; Familial hypercholesterolemia; Matrix metalloproteinases; Tissue inhibitors of matrix metalloproteinases

Indexed keywords

CLOFIBRATE; COLESTYRAMINE; COLLAGENASE; COMPACTIN; GELATINASE A; GELATINASE B; MATRIX METALLOPROTEINASE; PRAVASTATIN; PROBUCOL; TISSUE INHIBITOR OF METALLOPROTEINASE 2;

ADULT; ARTICLE; AUTOPSY; CASE REPORT; EXTRACELLULAR MATRIX; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERLIPOPROTEINEMIA TYPE 2; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADULT; ANTICHOLESTEREMIC AGENTS; CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; DILATATION, PATHOLOGIC; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LYMPHOCYTES; MACROPHAGES; MALE; METALLOENDOPEPTIDASES; MUSCLE, SMOOTH, VASCULAR; PLASMA CELLS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0033398165     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Goldstein JL, Brown MS, Hobbs HH. Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. 7th ed. New York: McGraw Hill,; 1995. p. 1981-2030.
2. Hobbs HH, Brown MS, Goldstein JL. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1992;1:445-66.
3. Mabuchi H, Koizumi J, Shimizu M, Takeda R. The Hokuriku FH-CHD Study Group. Development of coronary heart disease in familial hypercholesterolemia. Circulation 1989;79: 225-32.
4. Mabuchi H, Miyamoto S, Ueda K, Oota M, Takegoshi T, Wakasugi T, et al. Causes of death in patients with familial hypercholesterolemia. Atherosclerosis 1986;61:1-6.
5. Genda A, Nakayama A, Shimizu M, Nunoda S, Sugihara N, Suematsu T, et al. Coronary angiographic characteristics in Japanese patients with heterozygous familial hypercholesterolemia. Atherosclerosis 1987;66:29-36.
6. Sudhir K, Ports TA, Amidon TM, Goldberger JJ, Bhushan V, Kane JP, et al. Increased prevalence of coronary ectasia in heterozygous familial hypercholesterolemia. Circulation 1995;91:1375-80.
7. Birkedal-Hansen H. Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995;7:728-35.
8. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997;17:1859-67.
9. Thompson RW, Holmes DR, Mertens RA, Liao S, Botney MD, Mecham RP, et al. Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages. J Clin Invest 1995;96:318-26.
10. Schneiderman J, Bordin GM, Engelberg I, Adar R, Seiffert D, Thinnes T, et al. Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion. J Clin Invest 1995;96:639-45.
11. McMillan WD, Patterson BK, Keen RR, Shively VP, Cipollone M, Pearce WH. In situ localization and quantification of mRNA for 92-kD type IV collagenase and its inhibitor in aneurysmal, occlusive, and normal aorta. Arterioscler Thromb Vase Biol 1995;15:1139-44.
12. Freetone T, Turner RJ, Coady A, Higman DJ, Greenhalgh RM, Powell JT. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler Thromb Vase Biol 1995;15:1145-51.
13. Li Z, Li L, Zielke R, Cheng L, Xiao R, Crow MT, et al. Increased expression of 72-kd type IV collagenase (MMP-2) in human aortic atherosclerotic lesions. Am J Pathol 1996;148: 121-8.
14. Freestone T, Turner RJ, Higman DJ, Lever MJ, Powell JT. Influence of hypercholesterolemia and adventitial inflammation on the development of aortic aneurysm in rabbits. Arterioscler Thromb Vac Biol 1997;17:10-7.
15. Knox JB, Sukhova GK, Whittemore AD, Libby P. Evidence for altered balance between matrix metalloproteinases and their inhibitors in human aortic disease. Circulation 1997;95:205-12.
16. McMillan WD, Tamarina NA, Cipollone M, Johnson DA, Parker MA, Pearce WH. Size matters: the relationship between MMP-9 expression and aortic diameter. Circulation 1997;96:2228-32.
17. Mabuchi H, Haba T, Tatami R, Miyamoto S, Sakai Y, Wakasugi T, et al. Effects of an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase on serum lipoproteins and ubiquinone-10 levels in patients with familial hypercholesterolemia. N Engl J Med 1981;305:478-82.
18. Mabuchi H, Kamon N, Fujita H, Michishita I, Takeda M, Kajinami K, et al. Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia. Metabolism 1987;36:475-9.
19. Mabuchi H, Michishita I, Takeda M, Fujita H, Koizumi J, Takeda R, et al. A new low density lipoprotein apheresis system using two dextran sulfate cellulose columns in an automated column regenerating unit (LDL continuous apheresis). Atherosclerosis 1987;68:19-25.
20. Zhang J, Fujimoto N, Iwata K, Sakai T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 1 (interstitial collagenase) using monoclonal antibodies. Clin Chim Acta 1993;219:1-14.
21. Fujimoto N, Mouri N, Iwata K, Ohuchi E, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993;221:91-103.
22. Fujimoto N, Hosokawa N, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies. Clin Chim Acta 1994;231:79-88.
23. Fujimoto N, Zhang J, Iwata K, Shinya T, Okada Y, Hayakawa T. A one-step sandwich enzyme immunoassay for tissue inhibitor of metalloproteinase-2 using monoclonal antibodies. Clin Chim Acta 1993;220:31-45.
24. Oliveros RA, Falsetti HL, Carroll RJ, Heinle RA, Ryan GF. Atherosclerotic coronary artery aneurysm: report of five cases and a review of the literature. Arch Intern Med 1974; 134:1072-6.
25. Swaye PS, Fisher LD, Litwin P, Vignola PA, Judkins MP, Kemp HG, et al. Aneurysmal coronary artery disease. Circulation 1983;67:134-8.
26. Okada Y, Katsuda S, Okada Y, Nakanishi I. An elastinolytic enzyme detected in the culture medium of human arterial smooth muscle cells. Cell Biol Int 1993;17:863-9.
27. Katsuda S, Okada Ya, Okada Yo, Imai K, Nakanishi I. Matrix metalloproteinase-9 (92-kd gelatinase/type IV collagenase equals gelatinase-B) can degrade arterial elastin. Am J Pathol 1993;145:1208-18.
28. Kim SC, Singh M, Huang J, Prestigiacomo CJ, Winfree CJ, Solomon RA, et al. Matrix metalloproteinase-9 in cerebral aneurysms. Neurosurgery 1997;41:642-6.
29. Sohma Y, Sasano H, Shiga R, Saeki S, Suzuki T, Nagura H, et al. Accumulation of plasma cells in atherosclerotic lesions of Watanabe heritable hyperlipidemic rabbits. Proc Natl Acad Sci U S A 1995;92:4937-41.